Todd Roberts
Medical Oncology · Fairhaven, MANPI 1003871336
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,996 of the $2,302 with a category attached, or 86.7%. It is spread thinly across 20 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for medical oncology clinicians in MA, where the typical reported total is $2,567.
Across 56 payments — averaging $41.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$358
- Gilead$304
- Johnson & Johnson$274
- AbbVie$221
- E.r. Squibb & Sons, L.L.C.$172
- Novartis$139
- plus $834 from 14 others
Across 8 payments — averaging $6015.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bristol Myers Squibb$48K
What the payments were for
- Food & beverage$1,99687%
- Education$30613%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 5 | $358 |
| Gilead(2 entities) | 6 | $304 |
| Johnson & Johnson | 6 | $274 |
| AbbVie | 7 | $221 |
| E.r. Squibb & Sons, L.L.C. | 3 | $172 |
| Novartis | 3 | $139 |
| Bristol Myers Squibb | 5 | $125 |
| Amgen | 2 | $124 |
| Janssen Scientific Affairs, LLC | 3 | $117 |
| Jazz Pharmaceuticals Inc. | 2 | $111 |
| Incyte Corporation | 4 | $103 |
| Adaptive Biotechnologies Corporation | 2 | $45 |
| Rigel Pharmaceuticals, Inc. | 1 | $35 |
| Syndax Pharmaceuticals, Inc. | 1 | $34 |
| Legend Biotech USA Inc. | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Geron Corporation | 1 | $24 |
| ADC Therapeutics America, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Kyowa Kirin, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,302 in reported general payments places this provider in the 45th percentile of 308 medical oncology providers in Massachusetts.
Other medical oncology in Fairhaven
- George DemetriBoston$1.6M
- Keith FlahertyBoston$932K
- Alicia MorgansBoston$690K
- James O'LearyWaltham$508K
- Pasi Antero JanneBoston$458K
- Robert HaddadBoston$451K
- Irene GhobrialBoston$431K
- Joaquin Bellmunt MolinsBoston$415K
- Mary DonnellyGardner$392K
- Jeremy AbramsonBoston$334K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.